| Dr Eduardo Meirelles, MD, PHD | |
|
1110 N. 35th Ave, Yakima, WA 98902 | |
| (509) 834-7050 | |
| (509) 834-7051 |
| Full Name | Dr Eduardo Meirelles |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 1110 N. 35th Ave, Yakima, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508843970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD00047704 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eduardo Meirelles, MD, PHD 1110 N. 35th Ave, Yakima, WA 98902 Ph: (509) 834-7050 | Dr Eduardo Meirelles, MD, PHD 1110 N. 35th Ave, Yakima, WA 98902 Ph: (509) 834-7050 |
News Archive
This bacterium, Escherichia coli K1, is the most common cause of meningitis in premature infants and the second most common cause of the disease in newborns. "The ineffectiveness of antibiotics in treating newborns with meningitis and the emergence of antibiotic-resistant strains of bacteria require new strategies," explains Nemani V. Prasadarao, PhD, associate professor of infectious disease at Childrens Hospital Los Angeles.
​Community-based efforts to change the environment are proving to be an effective way of encouraging more physical activity and nutrition among school-age children, according to findings announced today from Kaiser Permanente.
Bionas GmbH announces the launch of its new Bionas® adcon reader for impedance-based, cellular analysis. The Bionas adcon reader technology is based on real-time monitoring of cellular impedance, thus giving real-time data about cell adhesion, membrane integrity, cellular morphology and cell proliferation for applications in toxicology, oncology, receptor signaling as well as the quality management of cells.
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase-III study to report findings in this setting.The new results from the OPTIMAL trial were reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
In an ongoing effort to mirror the ability of biological tissues to respond rapidly and appropriately to changing environments, scientists from the McGowan Institute for Regenerative Medicine have synthesized a single, multifunctional polymer material that can decontaminate both biological and chemical toxins. They described the findings recently in Biomaterials.
› Verified 2 days ago
Dr. Dave S Atteberry, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6101 Summitview Ave Ste 200, Yakima, WA 98908 Phone: 509-902-8857 Fax: 509-902-8855 | |
Leslie R Bornfleth, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 111 S 11th Ave, Suite 321, Yakima, WA 98902 Phone: 509-248-3954 Fax: 509-248-3955 | |
Voderbet C Kamath, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 307 S 12th Ave, Ste 19, Yakima, WA 98902 Phone: 509-469-1446 Fax: 509-469-1905 |